Aligos Therapeutics Inc. (ALGS): Price and Financial Metrics
ALGS Price/Volume Stats
| Current price | $7.21 | 52-week high | $46.80 |
| Prev. close | $7.14 | 52-week low | $3.76 |
| Day low | $6.88 | Volume | 87,500 |
| Day high | $7.46 | Avg. volume | 199,872 |
| 50-day MA | $6.09 | Dividend yield | N/A |
| 200-day MA | $15.42 | Market Cap | 44.08M |
ALGS Stock Price Chart Interactive Chart >
Aligos Therapeutics Inc. (ALGS) Company Bio
Aligos Therapeutics, Inc. develops targeted, curative therapies for hepatologic diseases and viral infections. It engages in building a pipeline of drug candidates which targets multiple clinically validated mechanisms of action and are designed to achieve functional cure for CHB and become transformative treatment options for COVID-19 and NASH. The company was founded by Lucinda Quan and Lawrence M. Blatt on February 05, 2018 and is headquartered in South San Francisco, CA.
ALGS Price Returns
| 1-mo | 25.72% |
| 3-mo | -20.94% |
| 6-mo | -82.18% |
| 1-year | -17.60% |
| 3-year | -77.29% |
| 5-year | N/A |
| YTD | -81.90% |
| 2024 | 140.00% |
| 2023 | -30.32% |
| 2022 | -91.97% |
| 2021 | -57.07% |
| 2020 | N/A |
Loading social stream, please wait...